Receptor tyrosine kinases
Author(s)
Bibliographic Information
Receptor tyrosine kinases
（Advances in cancer research, v. 147）
Academic Press, an imprint of Elsevier, 2020
Available at 5 libraries
Description and Table of Contents
Description
Receptor Tyrosine Kinases, Volume 147 in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research in the area of Receptor Tyrosine Kinases (RTKs) in the context of major basic science and translational advances, their importance in the development of a large number of anti-cancer drugs over the decades, and a peek into postulated advances in the coming decades for a number of RTK. Chapters in this new release are contributed by a group of International leading scientists who have a rich history in this field.
Table of Contents
Contributions from:Yosef Yarden, Ph.D., Weizmann Institute of Science, ISRAELRakesh Kumar, Ph.D., Rajiv Gandhi Center for Biotechnology, INDIAPaul Fisher, M.D., Ph.D., Virginia Commonwealth University, School of Medicine, USAMark Moasser, M.D., University of California San Francisco, USA William J. Muller, Ph.D., McGill University, CANADA Ravi Salgia, M.D., Ph.D., City of Hope's Comprehensive Cancer Center, USARenata Pasqualini, Ph.D., Rutgers NJ School of Medicine, USAFernanda Staquicini, Ph.D., Rutgers NJ School of Medicine, USAM. Radhakrishna Pillai, Ph.D., Rajiv Gandhi Center for Biotechnology, INDIAMien-Chie Hung, Ph.D., China Medical University, TAIWANE. Prem Reddy, Ph.D., Mount Sanai School of Medicine, USADoug Yee, M.D., Masonic Cancer Center University of Minnesota, USANandini Verma, Ph.D., Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, INDIA Masakazu Toi, M.D., Ph.D., Kyoto University School of Medicine, JAPANLouis Chow, M.D., UNIMED Medical Institute, Hong Kong, CHINALuis Marques da Costa, M.D., Ph.D., University of Lisbon School of Medicine, PORTUGAL
by "Nielsen BookData"